New York Medical College

NYMC Examines:

Heart Disease

When the human body fails, it is foolish to weigh one cause of death against another. What sense is there in pondering whether a genetic defect that kills inexorably is worse than a lingering death from cancer?

Three Schools, Three Perspecitves


Heart disease may seem swifter and more orderly, but only if the implications of congestive heart failure, stroke, arrhythmias and other concomitant disorders under the cardiovascular umbrella are ignored. Fact is, despite a 36 percent drop in mortality over the last 25 years, heart disease is still the number one killer in the nation—of men and women. If this dubious advantage is ever to be vanquished, the odds are that research will earn the reward.

At New York Medical College, cardiovascular disease has long been the linchpin of two Research Program Project Grants bestowed on the departments of Physiology and Pharmacology. These NIH awards support a broadly based, multifaceted research program with a specific objective. A grant calls for the organized efforts of several scientists to work not only on their own projects, but also as a group examining the various components of a central theme. The investigators make use of common resources, instruments and core facilities to enhance their studies in a quality and cost-effective way.